1. Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers;Page;Eur Urol,2019
2. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients;Kote-Jarai;Br J Cancer,2011
3. Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death;Na;Eur Urol,2017
4. BRCA germline mutations in prostate cancer: the future is tailored;Crocetto;Diagnostics (Basel),2021
5. Hereditary prostate cancer: genes related, target therapy and prevention;Vietri;Int J Mol Sci,2021